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The development and application of fed-batch strategies have greatly contributed to the improvement of the 
productivity of cell culture processes. However, in such processes, lactate and ammonia accumulation in the 
culture medium over time can have detrimental impacts on cell growth and product quality. Continuous cell lines 
typically exhibit an inefficient metabolism whereby most of the pyruvate derived from glucose is diverted to lactate 
and only a small percentage is incorporated into the TCA cycle. Thus, further process improvements can be 
expected by combining the application of rational fed-batch strategies with targeted metabolic engineering of cells 
to reduce waste metabolite accumulation.  
We have previously reported the establishment of a PYC2-expressing CHO cell line that exhibits a significantly 
altered lactate metabolism compared to its parental cell line; the ensuing reduction in waste metabolite 
accumulation is associated with a prolonged exponential growth phase, leading to significant increases in both 
maximum cell density and product titer in batch culture.  
In this work, we demonstrate further process enhancements by cultivating the PYC2-expressing cells in fed-batch 
mode. Unlike the parental cell line, even under high nutrient levels, the engineered cells maintained their highly 
efficient metabolism characterized by low lactate\glucose and ammonia\glutamine molar ratios. This effectively 
alleviates the need to control substrates at low levels to avoid waste accumulation, a strategy which can negatively 
impact product quality. And unlike nutrient substitutions which are often accompanied by cell growth reduction, 
the decrease in lactate accumulation is associated with an increased in maximum cell density translating into a 
net gain (20%) in final volumetric productivity. To further characterize the process, isotopic tracer studies were 
conducted to analyze the fate of the main nutrients and various product characterizations were performed to 
assess the impact of this cellular engineering approach on antibody quality. 
 
 
